Particle.news

Download on the App Store

White House Set to Link Prenatal Tylenol Use to Autism Risk, Spotlight Leucovorin

The move faces sharp skepticism from leading medical groups, with no public, peer‑reviewed report yet.

Overview

  • President Trump is slated to deliver the autism announcement today from the Oval Office alongside HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz.
  • Reports indicate officials will advise pregnant patients to limit acetaminophen use to treating high fevers and will flag low maternal folate as a risk factor.
  • Leucovorin, a form of folate, is expected to be highlighted as a possible therapy to reduce symptoms in some people with autism.
  • Tylenol maker Kenvue and major medical organizations dispute a causal link and maintain that acetaminophen remains an appropriate option in pregnancy when used as directed.
  • Researchers describe mixed evidence, with observational reviews noting associations, while a large 2024 sibling‑controlled JAMA study from Sweden found no increased autism risk.